Advertisement

PTHL

Pheton Holdings Ltd Class A Ordinary Shares

Healthcare · USD

Set alert

Price alert · PTHL

All alert types
0.28 USD 0.00 0.00%
As of Mar 19, 2026 Extended hours 0.94 +233.04%
Bid
0.86 × 2
Ask
0.89 × 2
0.2714 Day range 0.30
3.32 52-week range 6.45
YTD
-33.10%
1 year
-91.89%
Open
0.2714
Prev close
0.2815
Mkt cap
85.74M
Vol
106.32K
Avg vol
144.53K
EPS
-0.03
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2714
High
0.30
Forward P/E
0.00
Beta
0.00
Short ratio
0.00
Inst. own
2.16%
Dividend
0.00
Ex-div date
50-d avg
4.43
200-d avg
4.51
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for PTHL has not been loaded yet. Try again in a moment.

Key statistics

Market cap
85.74M
Enterprise value
50.40M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
149.81
Price / book
4050.00
EPS (TTM)
-0.03
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-77.36%
Revenue (TTM)
572.29K
Revenue growth
-21.10%
Free cash flow
0
Total cash
17.85K
Total debt
377.65K
Return on equity
-188.15%
Shares outstanding
6.58M
Short % of float
0.00%
50-day average
4.43
200-day average
4.51

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
PTHL Revenue — annual 448.20K
2021-FY 20212022-FY 20222023-FY 20232024-FY 2024
PTHL Net income — annual -660.59K
2021-FY 20212022-FY 20222023-FY 20232024-FY 2024
PTHL EPS — annual -0.052
2021-FY 20212022-FY 20222023-FY 20232024-FY 2024

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

Sector
Healthcare
Industry
Medical Devices
Country
China
Website
ftzy.com.cn

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on PTHL — it syncs with the Stock Master app.

Institution ownership

PTHL institution ownership
Holder% heldSharesValueReported
Citadel Advisors Llc1.85%121,187490.81KSep 29, 2024
HRT Financial LP0.32%21,11585.52KSep 29, 2024
Advertisement